Bioequivalence & Bioavailability Bioequivalence of a New Generic Formulation of Erlotinib Hydrochloride 150 mg Tablets versus Tarceva in Healthy Volunteers under Fasting Conditions

Abstract

Erlotinib is a quinazolinamine with the chemical name N-(3ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine [1]. Erlotinib is available in the market as the hydrochloride salt [1]. It is manufactured by OSI pharmaceuticals, Inc. and Genentech in the USA and by Roche in the EU under the trade name of Tarceva [2]. Tarceva is available in the market in… (More)

4 Figures and Tables

Topics

  • Presentations referencing similar topics